Received May 24, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
received only the diluent component of Shingrix; received only the diluent component of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 22-APR-2026, the patient received the 1st dose of Shingrix. On 22-APR-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: received only the diluent component of Shingrix) and inappropriate preparation of medication (Verbatim: received only the diluent component of Shingrix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 18-MAY-2026 Healthcare provider wanted to know how to proceed with a patient that may have received only the diluent component of Shingrix as a first dose. The batch number was not provided upon follow- up with the reporter.